These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31017086)

  • 1. Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer.
    Williams SB; Hudgins HK; Ray-Zack MD; Chamie K; Smaldone MC; Boorjian SA; Daneshmand S; Black PC; Kamat AM; Goebell PJ; Seiler R; Schmitz-Drager B; Nawroth R; Baillargeon J; Klaassen Z; Kulkarni GS; Kim SP; Lee EK; Holzbeierlein JM; Hollenbeck BK; Gore JL
    Eur Urol Oncol; 2019 Mar; 2(2):119-125. PubMed ID: 31017086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel.
    Bruins HM; Veskimäe E; Hernández V; Neuzillet Y; Cathomas R; Compérat EM; Cowan NC; Gakis G; Espinós EL; Lorch A; Ribal MJ; Rouanne M; Thalmann GN; Yuan Y; der Heijden AGV; Witjes JA
    Eur Urol Oncol; 2020 Apr; 3(2):131-144. PubMed ID: 31866215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Renal Function.
    Sari Motlagh R; Ghoreifi A; Yanagisawa T; Kawada T; Kikic Z; Gill I; Daneshmand S; Djaladat H; Shariat SF
    Eur Urol Focus; 2024 Jan; 10(1):169-181. PubMed ID: 37442723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients.
    Psutka SP; Barocas DA; Catto JWF; Gore JL; Lee CT; Morgan TM; Master VA; Necchi A; Rouprêt M; Boorjian SA
    Eur Urol Oncol; 2018 Sep; 1(4):292-304. PubMed ID: 31100250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
    Gakis G; Black PC; Bochner BH; Boorjian SA; Stenzl A; Thalmann GN; Kassouf W
    Eur Urol; 2017 Apr; 71(4):545-557. PubMed ID: 27720534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer.
    Ripping TM; Witjes JA; Meijer RP; van Rhijn BWG; Oddens JR; Goossens-Laan CA; Mulder SF; van Moorselaar RJA; Kiemeney LA; Aben KKH
    Urol Oncol; 2020 Dec; 38(12):935.e9-935.e16. PubMed ID: 32917503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    Veskimäe E; Neuzillet Y; Rouanne M; MacLennan S; Lam TBL; Yuan Y; Compérat E; Cowan NC; Gakis G; van der Heijden AG; Ribal MJ; Witjes JA; Lebrét T
    BJU Int; 2017 Jul; 120(1):12-24. PubMed ID: 28220653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative nutrition for the treatment of bladder cancer by radical cystectomy.
    Burden S; Billson HA; Lal S; Owen KA; Muneer A
    Cochrane Database Syst Rev; 2019 May; 5(5):CD010127. PubMed ID: 31107970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate.
    Goossens-Laan CA; Gooiker GA; van Gijn W; Post PN; Bosch JL; Kil PJ; Wouters MW
    Eur Urol; 2011 May; 59(5):775-83. PubMed ID: 21310525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis.
    Tellini R; Mari A; Muto G; Cacciamani GE; Ferro M; Stangl-Kremser J; Campi R; Soria F; Rink M; Xylinas E; Minervini A; Briganti A; Montorsi F; Roupret M; Shariat SF; Moschini M;
    Eur Urol Oncol; 2021 Aug; 4(4):580-593. PubMed ID: 33160975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder.
    Stensland KD; Zaid H; Broadwin M; Sorcini A; Canes D; Galsky M; Moinzadeh A
    Eur Urol Oncol; 2020 Aug; 3(4):509-514. PubMed ID: 31411987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review.
    Boström PJ; Jensen JB; Jerlström T; Arum CJ; Gudjonsson S; Ettala O; Syvänen KT
    Scand J Urol; 2020 Aug; 54(4):267-276. PubMed ID: 32516016
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating the cost-utility of intravesical Bacillus Calmette-Guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK.
    Grabe-Heyne K; Henne C; Odeyemi I; Pöhlmann J; Ahmed W; Pollock RF
    J Med Econ; 2023; 26(1):411-421. PubMed ID: 36897006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.
    Williams SB; Huo J; Chamie K; Hu JC; Giordano SH; Hoffman KE; Dinney CPN; Kamat AM; Shih YT
    Eur Urol Focus; 2017 Apr; 3(2-3):258-264. PubMed ID: 28753760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis.
    Gild P; Wankowicz SA; Sood A; von Landenberg N; Friedlander DF; Alanee S; Chun FKH; Fisch M; Menon M; Trinh QD; Bellmunt J; Abdollah F
    Urol Oncol; 2018 Oct; 36(10):469.e1-469.e11. PubMed ID: 30139659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining a "High Volume" Radical Cystectomy Hospital: Where Do We Draw the Line?
    Arora S; Keeley J; Patel A; Eleswarapu SV; Bronkema C; Alanee S; Menon M
    Eur Urol Focus; 2020 Sep; 6(5):975-981. PubMed ID: 30772360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review.
    Smith AB; Crowell K; Woods ME; Wallen EM; Pruthi RS; Nielsen ME; Lee CT
    Eur Urol Focus; 2017 Feb; 3(1):136-143. PubMed ID: 28720359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery?
    Moschini M; Simone G; Stenzl A; Gill IS; Catto J
    Eur Urol Focus; 2016 Apr; 2(1):19-29. PubMed ID: 28723446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.